{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T08:50:59Z","timestamp":1782118259143,"version":"3.54.5"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,29]],"date-time":"2027-01-29T00:00:00Z","timestamp":1801180800000},"content-version":"am","delay-in-days":273,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.expneurol.2026.115665","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:16:36Z","timestamp":1769127396000},"page":"115665","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Molecular and biochemical insights into dysregulation of glycosphingolipid metabolism in a mouse model of lysosomal free sialic acid storage disorder"],"prefix":"10.1016","volume":"399","author":[{"given":"Marya S.","family":"Sabir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahin S.","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petcharat","family":"Leoyklang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjan","family":"Huizing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Gahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances M.","family":"Platt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May Christine V.","family":"Malicdan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2026.115665_bb0005","unstructured":"Adams, D., Wasserstein, M., 2020. Free sialic acid storage disorders, in: Adam, M.P., Feldman, J., Mirzaa, G.M., Pagon, R.A., Wallace, S.E., Bean, L.J.H., Gripp, K.W., Amemiya, A. (eds.), GeneReviews((R)), Seattle (WA)."},{"key":"10.1016\/j.expneurol.2026.115665_bb0010","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1001\/archneur.1979.00500380058006","article-title":"\u201cSalla disease\u201d: a new lysosomal storage disorder","volume":"36","author":"Aula","year":"1979","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.expneurol.2026.115665_bb0015","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1086\/303077","article-title":"The spectrum of SLC17A5-gene mutations resulting in free sialic acid-storage diseases indicates some genotype-phenotype correlation","volume":"67","author":"Aula","year":"2000","journal-title":"Am. J. Hum. Genet."},{"issue":"87\u201391","key":"10.1016\/j.expneurol.2026.115665_bb0020","article-title":"A new patient with intermediate severe Salla disease with hypomyelination: a literature review for Salla disease","volume":"74","author":"Barmherzig","year":"2017","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.expneurol.2026.115665_bb0025","series-title":"EnhancedVolcano: Publication-Ready Volcano Plots With Enhanced Colouring and Labeling","author":"Blighe","year":"2018"},{"key":"10.1016\/j.expneurol.2026.115665_bb0030","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1042\/bj2680621","article-title":"Defective glucuronic acid transport from lysosomes of infantile free sialic acid storage disease fibroblasts","volume":"268","author":"Blom","year":"1990","journal-title":"Biochem. J."},{"key":"10.1016\/j.expneurol.2026.115665_bb0035","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2174\/1566523218666180404162622","article-title":"Genetics and therapies for GM2 Gangliosidosis","volume":"18","author":"Cachon-Gonzalez","year":"2018","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.expneurol.2026.115665_bb0040","doi-asserted-by":"crossref","first-page":"21738","DOI":"10.1074\/jbc.271.36.21738","article-title":"Metabolic processing of gangliosides by normal and Salla human fibroblasts in culture. A study performed by administering radioactive GM3 ganglioside","volume":"271","author":"Chigorno","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2026.115665_bb0045","doi-asserted-by":"crossref","first-page":"19316","DOI":"10.1074\/jbc.M110.130716","article-title":"Structure-function studies of the SLC17 transporter sialin identify crucial residues and substrate-induced conformational changes","volume":"285","author":"Courville","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2026.115665_bb0050","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/128_2013_419","article-title":"Why is N-glycolylneuraminic acid rare in the vertebrate brain?","volume":"366","author":"Davies","year":"2015","journal-title":"Top. Curr. Chem."},{"key":"10.1016\/j.expneurol.2026.115665_bb0055","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1021\/ac051632c","article-title":"Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in 1H NMR metabonomics","volume":"78","author":"Dieterle","year":"2006","journal-title":"Anal. Chem."},{"key":"10.1016\/j.expneurol.2026.115665_bb0060","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1039\/C5CC08838K","article-title":"A sequential bioorthogonal dual strategy: ManNAl and SiaNAl as distinct tools to unravel sialic acid metabolic pathways","volume":"52","author":"Gilormini","year":"2016","journal-title":"Chem. Commun. (Camb.)"},{"key":"10.1016\/j.expneurol.2026.115665_bb0065","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1055\/s-2008-1073028","article-title":"Phenotypic variation and magnetic resonance imaging (MRI) in Salla disease, a free sialic acid storage disorder","volume":"25","author":"Haataja","year":"1994","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.expneurol.2026.115665_bb0070","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13024-019-0339-z","article-title":"Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson\u2019s disease","volume":"14","author":"Huebecker","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.expneurol.2026.115665_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.135896","article-title":"Free sialic acid storage disorder: Progress and promise","volume":"755","author":"Huizing","year":"2021","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2026.115665_bb0080","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","article-title":"Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype","volume":"37","author":"Kim","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.expneurol.2026.115665_bb0085","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ymgme.2004.03.001","article-title":"Clinical, biochemical, and molecular diagnosis of a free sialic acid storage disease patient of moderate severity","volume":"82","author":"Kleta","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.expneurol.2026.115665_bb0090","doi-asserted-by":"crossref","first-page":"11958","DOI":"10.1074\/jbc.274.17.11958","article-title":"Molecular cloning and functional expression of two members of mouse NeuAcalpha2,3Galbeta1,3GalNAc GalNAcalpha2,6-sialyltransferase family, ST6GalNAc III and IV","volume":"274","author":"Lee","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2026.115665_bb0095","doi-asserted-by":"crossref","first-page":"W336","DOI":"10.1093\/nar\/gkab419","article-title":"LipidSig: a web-based tool for lipidomic data analysis","volume":"49","author":"Lin","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.expneurol.2026.115665_bb0100","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00234-002-0900-1","article-title":"A case of Salla disease with involvement of the cerebellar white matter","volume":"45","author":"Linnankivi","year":"2003","journal-title":"Neuroradiology"},{"key":"10.1016\/j.expneurol.2026.115665_bb0105","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.expneurol.2026.115665_bb0110","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1172\/JCI115136","article-title":"Sialic acid storage diseases. A multiple lysosomal transport defect for acidic monosaccharides","volume":"87","author":"Mancini","year":"1991","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.expneurol.2026.115665_bb0115","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.ymthe.2019.05.018","article-title":"Substrate reduction therapy for Sandhoff disease through inhibition of glucosylceramide synthase activity","volume":"27","author":"Marshall","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2026.115665_bb0120","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1042\/bj2180625","article-title":"Specificity studies on the oligosaccharide neuraminidase of human fibroblasts","volume":"218","author":"Mendla","year":"1984","journal-title":"Biochem. J."},{"key":"10.1016\/j.expneurol.2026.115665_bb0125","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1093\/glycob\/cws057","article-title":"Mammalian sialidases: physiological and pathological roles in cellular functions","volume":"22","author":"Miyagi","year":"2012","journal-title":"Glycobiology"},{"key":"10.1016\/j.expneurol.2026.115665_bb0130","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1021\/acs.jproteome.0c00082","article-title":"Lipidr: a software tool for data mining and analysis of lipidomics datasets","volume":"19","author":"Mohamed","year":"2020","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.expneurol.2026.115665_bb0135","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0065-2318(10)64007-3","article-title":"Sialidases in vertebrates: a family of enzymes tailored for several cell functions","volume":"64","author":"Monti","year":"2010","journal-title":"Adv. Carbohydr. Chem. Biochem."},{"key":"10.1016\/j.expneurol.2026.115665_bb0140","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1038\/sj.emboj.7600464","article-title":"Functional characterization of wild-type and mutant human sialin","volume":"23","author":"Morin","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.expneurol.2026.115665_bb0145","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1177\/08830738050200100601","article-title":"Novel form of intermediate salla disease: clinical and neuroimaging features","volume":"20","author":"Morse","year":"2005","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.expneurol.2026.115665_bb0150","doi-asserted-by":"crossref","first-page":"11489","DOI":"10.1074\/jbc.M111.313056","article-title":"Successful prediction of substrate-binding pocket in SLC17 transporter sialin","volume":"287","author":"Pietrancosta","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2026.115665_bb0155","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1042\/bj3630417","article-title":"Endolysosomal proteolysis and its regulation","volume":"363","author":"Pillay","year":"2002","journal-title":"Biochem. J."},{"key":"10.1016\/j.expneurol.2026.115665_bb0160","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0009-8981(95)06243-2","article-title":"Impairment of ganglioside metabolism in cultured fibroblasts from Salla patients","volume":"247","author":"Pitto","year":"1996","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.expneurol.2026.115665_bb0165","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1042\/BST20220711","article-title":"The expanding boundaries of sphingolipid lysosomal storage diseases; insights from Niemann-pick disease type C","volume":"51","author":"Platt","year":"2023","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.expneurol.2026.115665_bb0170","series-title":"Analysis of Glycosphingolipids From Animal Tissues. Protocols.io","author":"Priestman","year":"2024"},{"key":"10.1016\/j.expneurol.2026.115665_bb0175","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1212\/WNL.33.1.57","article-title":"Salla disease: a new lysosomal storage disorder with disturbed sialic acid metabolism","volume":"33","author":"Renlund","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2026.115665_bb0180","doi-asserted-by":"crossref","first-page":"26052","DOI":"10.1074\/jbc.M113.463562","article-title":"beta-glucosidase 2 (GBA2) activity and imino sugar pharmacology","volume":"288","author":"Ridley","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2026.115665_bb0185","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/978-3-642-55557-2_3","article-title":"Developmental expression and possible roles of gangliosides in brain development","volume":"32","author":"Rosner","year":"2003","journal-title":"Prog. Mol. Subcell. Biol."},{"key":"10.1016\/j.expneurol.2026.115665_bb0190","first-page":"S107","article-title":"A novel experimental mouse model to investigate a free sialic acid storage disorder (Salla disease)","volume":"135","author":"Sabir","year":"2022","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.expneurol.2026.115665_bb0195","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-12682-4","article-title":"Lysosomal free sialic acid storage disorder iPSC-derived neural cells display altered glycosphingolipid metabolism","volume":"15","author":"Sabir","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.expneurol.2026.115665_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.rare.2025.100065","article-title":"Changes in glycosphingolipid levels in plasma and cerebrospinal fluid of individuals with lysosomal free sialic acid storage disorder","volume":"3","author":"Sabir","year":"2025","journal-title":"Rare"},{"key":"10.1016\/j.expneurol.2026.115665_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195812","article-title":"Integration of genetic and metabolic features related to sialic acid metabolism distinguishes human breast cell subtypes","volume":"13","author":"Saeui","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.expneurol.2026.115665_bb0210","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s10545-008-0879-9","article-title":"Molecular physiology and pathophysiology of lysosomal membrane transporters","volume":"31","author":"Sagne","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.expneurol.2026.115665_bb0215","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ng1095-170","article-title":"Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism","volume":"11","author":"Sango","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.expneurol.2026.115665_bb0220","first-page":"1","article-title":"Exploration of the sialic acid world","volume":"75","author":"Schauer","year":"2018","journal-title":"Adv. Carbohydr. Chem. Biochem."},{"key":"10.1016\/j.expneurol.2026.115665_bb0225","doi-asserted-by":"crossref","first-page":"19063","DOI":"10.1074\/jbc.274.27.19063","article-title":"Accumulation of sialic acid in endocytic compartments interferes with the formation of mature lysosomes. Impaired proteolytic processing of cathepsin B in fibroblasts of patients with lysosomal sialic acid storage disease","volume":"274","author":"Schmid","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2026.115665_bb0230","series-title":"Handbook of Glycosyltransferases and Related Genes","first-page":"657","article-title":"ST3 beta-galactoside alpha-2,3-Sialyltransferase 3 (ST3GAL3)","author":"Schnaar","year":"2014"},{"key":"10.1016\/j.expneurol.2026.115665_bb0235","unstructured":"Schnaar, R.L., Suzuki, A., Stanley, P., 2009. Glycosphingolipids, in: Varki, A., Cummings, R.D., Esko, J.D., Freeze, H.H., Stanley, P., Bertozzi, C.R., Hart, G.W., Etzler, M.E. (eds.), Essentials of Glycobiology, Cold Spring Harbor (NY), 2nd ed."},{"key":"10.1016\/j.expneurol.2026.115665_bb0240","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.expneurol.2017.09.012","article-title":"Murine sialidase Neu3 facilitates GM2 degradation and bypass in mouse model of Tay-Sachs disease","volume":"299","author":"Seyrantepe","year":"2018","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2026.115665_bb0245","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/42408","article-title":"Functional rafts in cell membranes","volume":"387","author":"Simons","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2026.115665_bb0250","first-page":"433","article-title":"Brain involvement in Salla disease","volume":"20","author":"Sonninen","year":"1999","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.expneurol.2026.115665_bb0255","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/978-1-4684-7844-0_46","article-title":"Gangliosides and synaptic transmission","volume":"125","author":"Svennerholm","year":"1980","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.expneurol.2026.115665_bb0260","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0887-8994(01)00406-4","article-title":"Phenotypic spectrum of Salla disease, a free sialic acid storage disorder","volume":"26","author":"Varho","year":"2002","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.expneurol.2026.115665_bb0265","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/70585","article-title":"A new gene, encoding an anion transporter, is mutated in sialic acid storage diseases","volume":"23","author":"Verheijen","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.expneurol.2026.115665_bb0270","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0300-9084(01)01308-6","article-title":"Brain gangliosides: functional ligands for myelin stability and the control of nerve regeneration","volume":"83","author":"Vyas","year":"2001","journal-title":"Biochimie"},{"key":"10.1016\/j.expneurol.2026.115665_bb0275","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1042\/BST0381436","article-title":"Lysosomal compromise and brain dysfunction: examining the role of neuroaxonal dystrophy","volume":"38","author":"Walkley","year":"2010","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.expneurol.2026.115665_bb0280","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1002\/glia.20999","article-title":"Glycosphingolipid synthesis in cerebellar Purkinje neurons: roles in myelin formation and axonal homeostasis","volume":"58","author":"Watanabe","year":"2010","journal-title":"Glia"},{"key":"10.1016\/j.expneurol.2026.115665_bb0285","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1074\/jbc.M411295200","article-title":"Varied mechanisms underlie the free sialic acid storage disorders","volume":"280","author":"Wreden","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2026.115665_bb0290","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1073\/pnas.93.2.814","article-title":"Gangliosides are neuronal ligands for myelin-associated glycoprotein","volume":"93","author":"Yang","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488626000282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488626000282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T08:25:56Z","timestamp":1782116756000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488626000282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":58,"alternative-id":["S0014488626000282"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2026.115665","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular and biochemical insights into dysregulation of glycosphingolipid metabolism in a mouse model of lysosomal free sialic acid storage disorder","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2026.115665","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115665"}}